Dr Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Dr Jeanne Bolger brings over…

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

KU Leuven spin-off AstriVax raises…